Xenon Pharmaceuticals EPS Basic from Extraordinaries (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

41.51 +0.02 (+0.05%) USD | NASDAQ | Jan 21, 13:13

View EPS Basic from Extraordinaries (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Lexaria Bioscience Corp.	--
ProMIS Neurosciences, Inc.	--